Eighty years later, academic and cultural institutions the world over are deciding whether to reject the Sackler brothers’ children — not because of their religion but because of their actions.

Arthur Sackler Sr.: Deceased, amassed a significant fortune from medical advertising and trade publications. At the time of ...

The three brothers have all died, but other members of the family have retained control of Purdue Pharma and their wealth, estimated at about $11 billion two years ago. The Sackler name had been a ...

The family has remained virtually untouched since then. The three original Sackler brothers, all physicians, bought Purdue in 1952 and developed OxyContin in 1996. Six Sackler members sat on the ...

A previous version had bankruptcy court approval but was rejected last year by the U.S. Supreme Court because it protected members of the Sackler family from civil lawsuits even though none of ...

a deal that would have members of the Sackler family who own the company pay up to $7 billion. The filing is a milestone in a tumultuous legal saga that has gone on for more than five years.

NEW YORK, Feb 25 (Reuters) - Purdue Pharma told a U.S. bankruptcy judge on Tuesday that it will finalize a new bankruptcy plan in March, with the company's Sackler family owners potentially paying ...

The Justice Department argued that shielding the… OxyContin maker Purdue Pharma can start its transformation under a bankruptcy agreement that allows the members of the wealthy Sackler family ...

Advertisement A previous version had bankruptcy court approval but was rejected last year by the U.S. Supreme Court because it protected members of the Sackler family from civil lawsuits even ...

(AP) - Purdue Pharma asked a bankruptcy judge late Tuesday to consider the latest version of its plan to settle thousands of lawsuits over the toll of the powerful prescription painkiller OxyContin, a ...